Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome
Tóm tắt
Dominant
negative (DN) mutations in signal transducer and activator of transcription 3 (STAT3) are known to cause hyper-IgE syndrome, a rare primary immunodeficiency. STAT3 DN patients are prone to develop fungal infections, including chronic mucocutaneous candidiasis due to impaired IL-17-mediated immunity, and pulmonary aspergillosis. Despite having preserved phagocyte functions, STAT3 DN patients present connective tissue abnormalities and a defect in the immunological skin barrier. Fusarium species are ubiquitous molds, whose potential to infect humans depends on the host’s innate and cellular immune status. Our aim was to describe four STAT3 DN patients with fusariosis confined to the skin. Medical records were reviewed and summarized. Four patients, aged 4, 11, 30, and 33 years, presented with chronic skin lesions which started in the extremities. Two patients had remote lesions, and none had systemic involvement. Skin biopsies showed mycelial threads with deep inflammatory—occasionally granulomatous—infiltrates, reaching the dermis; cultures grew Fusarium solani. Response to treatment was heterogeneous, often requiring multimodal therapies, including topical antifungal preparations. In this work, we describe primary invasive cutaneous fusariosis as a syndromic entity in four STAT3 DN patients.
Tài liệu tham khảo
Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE Syndrome: molecular, cellular, and clinical features from a French National Survey. Medicine (Baltimore). 2012;91(4):e1-19.
Pilmis B, Puel A, Lortholary O, Lanternier F. New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect. 2016;22(8):681–7.
Heimall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol. 2010;38(1):32–8.
Danion F, Aimanianda V, Bayry J, Duréault A, Wong SSW, Bougnoux ME, et al. Aspergillus fumigatus infection in humans with STAT3-deficiency is associated with defective interferon-gamma and Th17 responses. Front Immunol. 2020;11:38.
Duréault A, Tcherakian C, Poiree S, Catherinot E, Danion F, Jouvion G, et al. Spectrum of pulmonary aspergillosis in hyper-IgE syndrome with autosomal-dominant STAT3 deficiency. J Allergy Clin Immunol Pract. 2019;7(6):1986-1995.e3.
Odio CD, Milligan KL, McGowan K, Rudman Spergel AK, Bishop R, Boris L et al. Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome. J Allergy Clin Immunol. 2015;136(5):1411–1413.e1–2
Nucci M, Anaissie E. Fusarium Infections in immunocompromised patients. Clin Microbiol Rev. 2007;20(4):695–704.
Nucci F, Nouér SA, Capone D, Nucci M. Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis. Clin Microbiol Infect. 2018;24(10):1105.e1-1105.e4.
Lionakis M, Kontoyiannis D. Fusarium infections in critically ill patients. Semin Respir Crit Care Med. 2004;25(02):159–69.
Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;20:27–46.
Nucci M, Jenks J, Thompson GR, Hoenigl M, dos Santos MC, Forghieri F, et al. Do high MICs predict the outcome in invasive fusariosis? J Antimicrob Chemother. 2021;76(4):1063–9.
Bouchand C, Nguyen D, Secretan PH, Vidal F, Guery R, Auvity S, et al. Voriconazole topical cream formulation: evidence for stability and antifungal activity. Int J Antimicrob Agents. 2020;56(3):106083.
Renner ED, Rylaarsdam S, Aňover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122(1):181–7.
Sano S, Chan KS, DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci. 2008;50(1):1–14.
Smeekens SP, Huttenhower C, Riza A, van de Veerdonk FL, Zeeuwen PLJM, Schalkwijk J, et al. Skin Microbiome imbalance in patients with STAT1/STAT3 Defects impairs innate host defense responses. J Innate Immun. 2014;6(3):253–62.
Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, et al. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother. 2010;54(10):4446–50.
Klein KC, Blackwood RA. Topical Voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. Pediatrics. 2006;118(2):e506–8.
Pyle JW, Holladay J, Molnar JA, Martin JS, DeFranzo AJ. Multiple modality treatment regimen in an aggressive resistant fungal hand infection: a case report. HAND. 2010;5(3):318–21.
Matthew D B, Lisa I, Jake E T. Multimodal Therapy for recalcitrant cutaneous fusarium solani infection in a patient with hyper-IgE syndrome. Dermatol Arch [Internet]. 2017 Jul 3 [cited 2020 Feb 28];1(2). Available from: https://scholars.direct/Articles/dermatology/dma-1-009.php?jid=dermatology
Shi M, Lu S, Li J, Cai W, Zhang J, Ma J, et al. Cutaneous fusariosis caused by Fusarium lichenicola in a child with hyper-immunoglobulin E syndrome. J Dermatol. 2020;47(2):181–4.